Humrich JY - Search Results

1

Metabolomic signature identifies HDL and apolipoproteins as potential biomarker for systemic sclerosis with interstitial lung disease.

Jendrek ST, Schmelter F, Schinke S, Hackel A, Graßhoff H, Lamprecht P, Humrich JY, Sina C, Müller A, Günther U, Riemekasten G. Jendrek ST, et al. Among authors: humrich jy. Respir Med. 2024 Nov-Dec;234:107825. doi: 10.1016/j.rmed.2024.107825. Epub 2024 Sep 30. Respir Med. 2024. PMID: 39357678 Free article.

2

When natural antibodies become pathogenic: autoantibodies targeted against G protein-coupled receptors in the pathogenesis of systemic sclerosis.

Akbarzadeh R, Müller A, Humrich JY, Riemekasten G. Akbarzadeh R, et al. Among authors: humrich jy. Front Immunol. 2023 Jun 8;14:1213804. doi: 10.3389/fimmu.2023.1213804. eCollection 2023. Front Immunol. 2023. PMID: 37359516 Free PMC article. Review.

3

Restoring regulation - IL-2 therapy in systemic lupus erythematosus.

Humrich JY, Riemekasten G. Humrich JY, et al. Expert Rev Clin Immunol. 2016 Nov;12(11):1153-1160. doi: 10.1080/1744666X.2016.1199957. Epub 2016 Jun 23. Expert Rev Clin Immunol. 2016. PMID: 27283871 Review.

4

Clinical trials: The rise of IL-2 therapy - a novel biologic treatment for SLE.

Humrich JY, Riemekasten G. Humrich JY, et al. Nat Rev Rheumatol. 2016 Dec;12(12):695-696. doi: 10.1038/nrrheum.2016.173. Epub 2016 Oct 20. Nat Rev Rheumatol. 2016. PMID: 27761021 No abstract available.

5

Low-dose IL-2 therapy - a complex scenario that remains to be further explored.

Humrich JY, Riemekasten G. Humrich JY, et al. Nat Rev Rheumatol. 2017 Jun;13(6):386. doi: 10.1038/nrrheum.2017.71. Epub 2017 May 11. Nat Rev Rheumatol. 2017. PMID: 28490788 No abstract available.

6

Low-dose interleukin-2 therapy for the treatment of systemic lupus erythematosus.

Humrich JY, Riemekasten G. Humrich JY, et al. Curr Opin Rheumatol. 2019 Mar;31(2):208-212. doi: 10.1097/BOR.0000000000000575. Curr Opin Rheumatol. 2019. PMID: 30562181 Review.

7

Low-Dose IL-2 Therapy in Autoimmune and Rheumatic Diseases.

Graßhoff H, Comdühr S, Monne LR, Müller A, Lamprecht P, Riemekasten G, Humrich JY. Graßhoff H, et al. Among authors: humrich jy. Front Immunol. 2021 Apr 1;12:648408. doi: 10.3389/fimmu.2021.648408. eCollection 2021. Front Immunol. 2021. PMID: 33868284 Free PMC article. Review.

8

[The unusual mimicker of a polymyositis].

Jendrek ST, Glatzel M, Pauli D, Schinke S, Humrich JY, Lamprecht P, Riemekasten G. Jendrek ST, et al. Among authors: humrich jy. Z Rheumatol. 2022 Oct;81(8):682-685. doi: 10.1007/s00393-022-01173-w. Epub 2022 Mar 29. Z Rheumatol. 2022. PMID: 35348848 Free PMC article. German.

9

Autoimmune pre-disease.

Bieber K, Hundt JE, Yu X, Ehlers M, Petersen F, Karsten CM, Köhl J, Kridin K, Kalies K, Kasprick A, Goletz S, Humrich JY, Manz RA, Künstner A, Hammers CM, Akbarzadeh R, Busch H, Sadik CD, Lange T, Grasshoff H, Hackel AM, Erdmann J, König I, Raasch W, Becker M, Kerstein-Stähle A, Lamprecht P, Riemekasten G, Schmidt E, Ludwig RJ. Bieber K, et al. Among authors: humrich jy. Autoimmun Rev. 2023 Feb;22(2):103236. doi: 10.1016/j.autrev.2022.103236. Epub 2022 Nov 24. Autoimmun Rev. 2023. PMID: 36436750 Review.

10

Low-dose interleukin-2 therapy: a promising targeted therapeutic approach for systemic lupus erythematosus.

Akbarzadeh R, Riemekasten G, Humrich JY. Akbarzadeh R, et al. Among authors: humrich jy. Curr Opin Rheumatol. 2023 Mar 1;35(2):98-106. doi: 10.1097/BOR.0000000000000924. Epub 2022 Dec 22. Curr Opin Rheumatol. 2023. PMID: 36563007 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47 results

Search Page

Filters